- Home
- BMY vs MCO Comparison
BMY vs MCO Comparison
Compare BMY & MCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BMY | MCO |
|---|---|---|
| Founded | 1887 | 1900 |
| Country | United States | United States |
| Employees | 32500 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.7B | 80.7B |
| IPO Year | N/A | 1998 |
Fundamental Metrics
Financial Performance| Metric | BMY | MCO |
|---|---|---|
| Price | $59.85 | $444.41 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 17 |
| Target Price | $61.93 | ★ $550.63 |
| AVG Volume (30 Days) | ★ 9.9M | 1.5M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 4.20% | 0.92% |
| EPS Growth | N/A | ★ 21.40 |
| EPS | N/A | ★ 13.67 |
| Revenue | N/A | ★ $4,204,100,000.00 |
| Revenue This Year | N/A | $8.55 |
| Revenue Next Year | N/A | $7.72 |
| P/E Ratio | ★ $17.26 | $32.59 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $42.52 | $378.71 |
| 52 Week High | $62.89 | $546.88 |
Technical Indicators
Market Signals| Indicator | BMY | MCO |
|---|---|---|
| Relative Strength Index (RSI) | 49.83 | 39.62 |
| Support Level | $59.23 | $402.28 |
| Resistance Level | $62.47 | $496.76 |
| Average True Range (ATR) | 1.14 | 12.45 |
| MACD | -0.40 | 1.37 |
| Stochastic Oscillator | 14.93 | 26.14 |
Price Performance
Historical ComparisonAbout BMY Bristol-Myers Squibb Company
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
About MCO Moody's Corporation
Moody's, along with S&P Ratings, is a leading provider of credit ratings on fixed-income securities. The ratings segment, Moody's Investors Service, includes corporates, structured finance, financial institutions, and public finance ratings. MIS represents a majority of the firm's profit and often (depending on bond issuance levels) a majority of the firm's revenue. The other segment, Moody's Analytics, consists of decision solutions, research and insights, and data and information.